M
Michele Tagliati
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 54
Citations - 6574
Michele Tagliati is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Deep brain stimulation & Dystonia. The author has an hindex of 35, co-authored 49 publications receiving 6146 citations. Previous affiliations of Michele Tagliati include New York University & Yeshiva University.
Papers
More filters
Journal ArticleDOI
Deep Brain Stimulation for Parkinson Disease: An Expert Consensus and Review of Key Issues
Jeff M. Bronstein,Michele Tagliati,Ron L. Alterman,Andres M. Lozano,Jens Volkmann,Alessandro Stefani,Fay B. Horak,Michael S. Okun,Kelly D. Foote,Paul Krack,Rajesh Pahwa,Jaimie M. Henderson,Marwan Hariz,Roy A.E. Bakay,Ali R. Rezai,William J. Marks,Elena Moro,Jerrold L. Vitek,Frances M. Weaver,Robert E. Gross,Mahlon R. DeLong +20 more
TL;DR: Recommendations are provided to patients, physicians, and other health care providers on several issues involving deep brain stimulation (DBS) for Parkinson disease (PD) to be considered in a select group of appropriate patients.
Journal ArticleDOI
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.
Laurie J. Ozelius,Geetha Senthil,Rachel Saunders-Pullman,Erin Ohmann,Amanda Deligtisch,Michele Tagliati,Ann L. Hunt,Christine Klein,Brian Henick,Susan M. Hailpern,Richard B. Lipton,Jeannie Soto-Valencia,Neil Risch,Susan B. Bressman +13 more
TL;DR: To the Editor: Most cases of Parkinson's disease are considered sporadic and idiopathic, although there is evidence of familial aggregation, and several monogenic forms have been identified.
Journal ArticleDOI
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.
William J. Marks,Raymond T. Bartus,Joao Siffert,Charles S Davis,Andres M. Lozano,Nicholas M. Boulis,Jerrold L. Vitek,Mark Stacy,Dennis A. Turner,Leonard Verhagen,Roy A.E. Bakay,Ray L. Watts,Barton L. Guthrie,Joseph Jankovic,Richard K. Simpson,Michele Tagliati,Ron L. Alterman,Matthew B. Stern,Gordon H. Baltuch,Philip A. Starr,Paul S. Larson,Jill L. Ostrem,John G. Nutt,Karl Kieburtz,Jeffrey H. Kordower,C. Warren Olanow +25 more
TL;DR: Intraputaminal AAV2-neurturin is not superior to sham surgery when assessed using the UPDRS motor score at 12 months, however, the possibility of a benefit with additional targeting of the substantia nigra and longer term follow-up should be investigated in further studies.
Journal ArticleDOI
Botulinum toxin type A in the treatment of upper extremity spasticity : A randomized, double-blind, placebo-controlled trial
David M. Simpson,D. N. Alexander,C. F. O'Brien,Michele Tagliati,A. S. Aswad,J. M. Leon,J. Gibson,J. M. Mordaunt,E. P. Monaghan +8 more
TL;DR: BTXA safely reduced upper extremity muscle tone in patients with chronic spasticity after stroke and reported significant improvement on the physician and patient Global Assessment of Response to Treatment at weeks 4 and 6 postinjection.
Journal ArticleDOI
Management of Referred Deep Brain Stimulation Failures: A Retrospective Analysis From 2 Movement Disorders Centers
Michael S. Okun,Michele Tagliati,Michael H. Pourfar,Hubert H. Fernandez,Ramon L. Rodriguez,Ron L. Alterman,Kelly D. Foote +6 more
TL;DR: To improve outcomes of deep brain stimulation (DBS) surgery by analyzing a series of patients who had suboptimal results from DBS, and proposes strategies to manage patients with DBS more effectively.